CASI Pharmaceuticals, Inc. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-11-09
4:13 pm
Purchase
2023-11-0913GCASI Pharmaceuticals, Inc.
CASI
Huang James2,427,000
18.000%
677,000increase
(+38.69%)
Filing
History
2023-06-22
9:15 pm
Purchase
2023-06-1613GCASI Pharmaceuticals, Inc.
CASI
Huang James1,750,000
13.000%
520,000increase
(+42.28%)
Filing
History
2023-04-18
4:00 pm
Purchase
2023-04-1413DCASI Pharmaceuticals, Inc.
CASI
WEI-WU HE, Ph.D.2,837,891
19.750%
2,837,891increase
(New Position)
Filing
History
2023-04-10
11:22 am
Purchase
2023-03-2913GCASI Pharmaceuticals, Inc.
CASI
Huang James1,230,000
9.200%
1,230,000increase
(New Position)
Filing
History
Goto Prev, 0, 1